Literature DB >> 12810086

Chemical complementation: small-molecule-based genetic selection in yeast.

Bahareh Azizi1, Eileen I Chang, Donald F Doyle.   

Abstract

Protein and metabolic engineering would greatly benefit from a general system linking the presence of a small molecule to the power of genetic selection. We use nuclear receptors to link the survival of Saccharomyces cerevisiae to the presence of small molecules through genetic selection, extending classical genetic complementation to a new "chemical complementation." In this system the Gal4 DNA-binding domain is fused to ligand-binding domains from two nuclear receptors, expressed in the strain PJ69-4A, and grown on plates containing known ligands for the receptors. Yeast survive on selective plates only in the presence of a nuclear receptor and the corresponding ligand. Mutagenesis can increase the sensitivity of chemical complementation. This system may be extended to engineer nuclear receptors for practically any small molecule through directed evolution coupled to genetic selection, and for performing metabolic engineering in yeast.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810086     DOI: 10.1016/s0006-291x(03)01039-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  A human vitamin D receptor mutant activated by cholecalciferol.

Authors:  Amanda M Ousley; Hilda S Castillo; Anna Duraj-Thatte; Donald F Doyle; Bahareh Azizi
Journal:  J Steroid Biochem Mol Biol       Date:  2011-03-10       Impact factor: 4.292

2.  Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules.

Authors:  Lauren J Schwimmer; Priyanka Rohatgi; Bahareh Azizi; Katherine L Seley; Donald F Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

3.  Conservation of estrogen receptor function in invertebrate reproduction.

Authors:  Brande L Jones; Chris Walker; Bahareh Azizi; Laren Tolbert; Loren Dean Williams; Terry W Snell
Journal:  BMC Evol Biol       Date:  2017-03-04       Impact factor: 3.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.